Pelthos Therapeutics Inc. — Form 8-K
Filed August 13, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
On August 12, 2026, Pelthos Therapeutics Inc. filed an 8-K disclosing Item 4.02 (Non-Reliance on Previously Issued Financial Statements or Related Audit Report). The filing provides no dollar amounts, specific restatement details, affected periods, or reasons for the restatement in the text provided. Only the filing header and metadata are present.
Why this rating
Restatement triggers audit-reliance loss and credibility damage for microcap ($6.7M); lack of detail suggests potential material error or audit breakdown. Relative to company size, very serious.
Extracted items
- 4.02 non-reliance / restatement
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.